Fairfax stock positions

[anshulp]

5 hours ago, nwoodman said:

 

Great post, and I think you are broadly right, but I would be slightly careful with the “$415m / 5x / sub-4x” framing.

 

The $415m is the disclosed cash purchase price. It is not necessarily the full economic cost to Sleep Country. Through the Chapter 11 sale, Sleep Country is buying all of the operating assets, but it will also assume certain operating liabilities and selected contracts/leases. So the real economic cost is probably higher than $415m, although still materially lower than the old enterprise value, because the funded debt and unwanted liabilities should largely be left behind.

 

That aside, I appreciated your post because it piqued my interest enough to put a few tokens in the jukebox, so to speak. File note and workbook attached.

Where I landed (after crunching various LLMs etc)

• Disclosed cash purchase price - $415m
• Analyst-estimated effective cost - $500–600m
• Stress-case effective cost - $650–700m

 

The $500–600m range is not a disclosed number. It is my attempt to account for selected operating liabilities, working-capital leakage, customer obligations, cure costs and initial integration / restructuring. The $650–700m range is more of a stress case if the leakage, assumed lease burden, or cure costs are worse than expected.

 

Where I agree with you is that this looks potentially very attractive if Sleep Country can restore buyer-owned EBITDA to something like $110m+. Sleep Number did about $78m adjusted EBITDA in FY2025, down from about $120m in FY2024, and Q1 2026 was ugly. But Q1 was distorted by weak demand, product transition, liquidity stress and operating deleverage. I do not think annualising Q1 tells you the normalised value of the asset.

The more useful question, and the thing I really care about, is whether Fairfax / Sleep Country are maintaining capital allocation discipline. To that end, I tried to answer:

What EBITDA does Sleep Country need for this to clear Fairfax’s 15% hurdle?

At around $550m effective cost, assuming roughly 55% FCF conversion and a 6x year-five value, I get required buyer-owned EBITDA of roughly $114m to clear a 15% mark-to-market IRR. That is not the same as saying the business immediately earns a 15% cash yield. The strict no-growth cash-yield test is tougher and requires EBITDA closer to $150m at the same cost / FCF conversion assumptions. But on a five-year mark-to-market basis, $114m looks like the key hurdle number.

That is important because it does not require a heroic demand recovery. It mostly requires cost-side execution:

• public-company cost removal;
• duplicated overhead reduction;
• store / lease optimisation;
• procurement and logistics efficiencies;
• some marketing efficiency.

So can Sleep Country take a distressed $78m EBITDA platform and create roughly $35–40m of buyer-specific EBITDA improvement?

That seems plausible to me, especially because this deal likely only makes sense under Sleep Country. A generic PE buyer probably does not get the same strategic benefits. Sleep Country already has category knowledge, vendor relationships, retail operating experience, digital sleep-brand experience and Fairfax permanent capital behind it.

Sleep Number is also not just a mattress-store chain. It has a recognised U.S. brand, installed customer base, smart-bed IP, SleepIQ software/data, app engagement, patents and a large U.S. footprint. I would not value that at some fantasy health-tech multiple, but I would not ignore it either. Inside Sleep Country, those assets may be worth more than they were inside an overlevered public company.

 

On the buybacks, I wholeheartedly agree. The historic capital allocation looks terrible in hindsight. Buying hundreds of millions of stock at very high prices while the balance sheet later collapses is exactly the sort of thing that transfers value from old equity to future distressed buyers. Painful for SNBR shareholders, but potentially attractive for Fairfax / Sleep Country.

 

Is this a game-changer for Fairfax? No. But it is another useful data point that Fairfax-owned subsidiaries are doing the kind of acquisitions one would hope for at this stage of the market: buying real assets from forced sellers, using industry knowledge, avoiding the obvious crowded trades, and still appearing to underwrite against a reasonable return hurdle.

 

There is also a management/culture option here. Stewart Schaefer has already shown he can build Sleep Country beyond a plain mattress retailer through Endy, Hush, Silk & Snow and Casper Canada. And the broader Sleep Country culture traces back to Christine Magee and the founding team, who built one of Canada’s best-known specialty retail brands. If that operating culture can now be applied to Sleep Number’s U.S. brand, IP, customer base and footprint under a cleaner balance sheet, Fairfax may have bought more than a cheap distressed asset, it may have bought an option on a much larger North American sleep platform.

So my read is:

• Bad outcome for old Sleep Number equity.
• Probably an acceptable outcome for creditors versus liquidation.
• Potentially good bolt-on for Sleep Country if effective cost is around $500–600m and buyer-owned EBITDA gets back above ~$110m.
• Very good deal if EBITDA gets to $140m+.

Much more marginal if EBITDA stalls around $80–100m or if assumed lease/cure costs are worse than expected.

The bigger Fairfax point is that this may actually make the original Sleep Country acquisition look better. Sleep Country is not just a mature Canadian mattress retailer; it can become a platform for distressed North American sleep-sector consolidation. This is exactly the kind of sub-level capital allocation that matters over time. Ultimately, my takeaway is that the deal only really makes sense under the Sleep Country umbrella. That is not a weakness. That may be the whole point.  There are far shinier things at the moment than mattresses, but the GMs on a humble mattress I still find quite staggering   

 

 

Sleep Number Analysis.xlsx 69.45 kB · 2 downloads Sleep Number Analysis.pdf 652.05 kB · 2 downloads

Good thoughts, thanks.

[nwoodman]

On 6/16/2026 at 2:27 AM, SafetyinNumbers said:

No, the purchaser is a new subsidiary that has been created to acquire the company.

Spot on from the MD&A:
 

“On June 15, 2026, the Company entered into a definitive arrangement agreement with 18013632 Canada Inc., a newly-

formed and wholly-owned subsidiary of Fairfax Financial Holdings Limited, and Fairfax Financial Holdings Limited,

in respect of a transaction whereby all of the issued and outstanding Class A Non-Voting shares and Class B Voting

shares of the Company will be acquired by 18013632 Canada Inc. pursuant to a plan of arrangement under the Canada

Business Corporations Act (the “Arrangement”). Completion of the Arrangement is subject to customary conditions,

including, among others, court approval, regulatory approvals, and the requisite shareholder approvals.”

 

A first pass
 

I had a brief look at this and I am still not sure how this deal clears a 15% IRR hurdle on the stand-alone numbers. At roughly 8x FY2026 EBITA and a mid-single-digit earnings yield on the equity value, it does not scream “fat pitch”. The base case still feels more like a mature Canadian consumer business than a “classic” Fairfax opportunity. But the deal starts to look more interesting if Port Moody is monetized well ($20-$30m?), margins continue to rebase higher, and Peller becomes a platform for smaller wine, craft beverage, import-agency and succession-driven family assets.

 

I was bracketing around the following crude return estimates and the benefits of Fairfax Ownership
 

Case	Return feel before credit benefit	Credit-rating benefit/Balance Sheet
No real estate monetization	9-10%	Minor
Port Moody monetized well	10-12%	Helpful but secondary
Port Moody + margin expansion	13-14%	Adds some bridge
Port Moody + platform roll-up	15% possible	Most valuable here

 

Arguably the more important signal is that John Peller is rolling over rather than just selling out. He knows the assets better than anyone, has already stepped back from operating leadership, and could presumably have taken cash. Instead, he appears to be choosing Fairfax as a long-term home for the family legacy and a partner with patient capital, better credit support, and a willingness to let the business compound outside the public market. That says something.

 

In fact it made me think about Buffett’s old pitch to appeal to family businesses: Berkshire as a permanent gallery rather than a trader of assets. Fairfax may be offering a Canadian version of that bargain, liquidity for public shareholders, continuity for the family name, and a permanent-capital owner that can back the next phase.
 

I would not call it obviously great yet, but I think I can see how it moves from “single-digit winery deal” toward “asset-backed platform with a credible path to low-teens, maybe 15% if execution is good.”  My concern is always “are they lowering the bar”?  So hopefully there is more to it than a superficial first pass reveals.  In this regard I would definitely give Fairfax the benefit of the doubt.

 

 

[Txvestor]

1 hour ago, nwoodman said:

Spot on from the MD&A:
 

“On June 15, 2026, the Company entered into a definitive arrangement agreement with 18013632 Canada Inc., a newly-

formed and wholly-owned subsidiary of Fairfax Financial Holdings Limited, and Fairfax Financial Holdings Limited,

in respect of a transaction whereby all of the issued and outstanding Class A Non-Voting shares and Class B Voting

shares of the Company will be acquired by 18013632 Canada Inc. pursuant to a plan of arrangement under the Canada

Business Corporations Act (the “Arrangement”). Completion of the Arrangement is subject to customary conditions,

including, among others, court approval, regulatory approvals, and the requisite shareholder approvals.”

 

A first pass
 

I had a brief look at this and I am still not sure how this deal clears a 15% IRR hurdle on the stand-alone numbers. At roughly 8x FY2026 EBITA and a mid-single-digit earnings yield on the equity value, it does not scream “fat pitch”. The base case still feels more like a mature Canadian consumer business than a “classic” Fairfax opportunity. But the deal starts to look more interesting if Port Moody is monetized well ($20-$30m?), margins continue to rebase higher, and Peller becomes a platform for smaller wine, craft beverage, import-agency and succession-driven family assets.

 

I was bracketing around the following crude return estimates and the benefits of Fairfax Ownership
 

Case	Return feel before credit benefit	Credit-rating benefit/Balance Sheet
No real estate monetization	9-10%	Minor
Port Moody monetized well	10-12%	Helpful but secondary
Port Moody + margin expansion	13-14%	Adds some bridge
Port Moody + platform roll-up	15% possible	Most valuable here

 

Arguably the more important signal is that John Peller is rolling over rather than just selling out. He knows the assets better than anyone, has already stepped back from operating leadership, and could presumably have taken cash. Instead, he appears to be choosing Fairfax as a long-term home for the family legacy and a partner with patient capital, better credit support, and a willingness to let the business compound outside the public market. That says something.

 

In fact it made me think about Buffett’s old pitch to appeal to family businesses: Berkshire as a permanent gallery rather than a trader of assets. Fairfax may be offering a Canadian version of that bargain, liquidity for public shareholders, continuity for the family name, and a permanent-capital owner that can back the next phase.
 

I would not call it obviously great yet, but I think I can see how it moves from “single-digit winery deal” toward “asset-backed platform with a credible path to low-teens, maybe 15% if execution is good.”  My concern is always “are they lowering the bar”?  So hopefully there is more to it than a superficial first pass reveals.  In this regard I would definitely give Fairfax the benefit of the doubt.

 

 

They quite literally have so many capital allocation options right now that lowering the bar makes no sense. Not the least of which is just buying back their own shares. Or clearing out the remaining outstanding ownership interests in their insurance subs. Yet they are borrowing $ to make this investment. So they likely have some plan. Both with this as well as Sleep Country, my concern is retail has never been an easy business. And neither is Food and Beverage. Recipe/Keg for example over the long term has not really generated any sort of impressive returns. 
As for the real estate angle, even if there was a ROI lift it would be a one time benefit, and not a recurrent scenario. It would be interesting to see how it plays out over the course of time. 
It's why I said every such decision should be benchmarked against a share buyback. 

[SafetyinNumbers]

3 minutes ago, Txvestor said:

They quite literally have so many capital allocation options right now that lowering the bar makes no sense. Not the least of which is just buying back their own shares. Or clearing out the remaining outstanding ownership interests in their insurance subs. Yet they are borrowing $ to make this investment.

I don’t think they are borrowing to make this investment. The borrowing happens at the holdco. I assume Peller will end up in the insurance subsidiaries. I think the borrowing is to replace the class K preferred in March. 

[SafetyinNumbers]

6 minutes ago, Txvestor said:

As for the real estate angle, even if there was a ROI lift it would be a one time benefit, and not a recurrent scenario. It would be interesting to see how it plays out over the course of time. 
It's why I said every such decision should be benchmarked against a share buyback. 

If the business is overcapitalized between inventory and real estate, it would not be a one time lift. It would be structural. Again, holdco decisions are not generally related to equity investments unless they are in insurance companies which include the minority interests and buybacks.